A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS) of MET compared to sorafenib for advanced hepatocellular carcinoma (HCC) patien...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Mol Hepatol
Auteurs principaux: Yang, Hyun, Woo, Hyun Young, Lee, Soon Kyu, Han, Ji Won, Jang, Bohyun, Nam, Hee Chul, Lee, Hae Lim, Lee, Sung Won, Song, Do Seon, Song, Myeong Jun, Oh, Jung Suk, Chun, Ho Jong, Jang, Jeong Won, Lozada, Angelo, Bae, Si Hyun, Choi, Jong Young, Yoon, Seung Kew
Format: Artigo
Langue:Inglês
Publié: The Korean Association for the Study of the Liver 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497665/
https://ncbi.nlm.nih.gov/pubmed/28494528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0071
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires